Can lung cancer screenings also help smokers kick the habit?
NCT ID NCT03059940
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study offers lung cancer screenings to smokers aged 50 and older who want to quit. Participants receive counseling and may also get FDA-approved smoking cessation drugs. The goal is to see which counseling approach works best for helping people stop smoking.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- smoking cessation counseling and questionnaires
- What this could lead to
- If successful, this could point toward more effective ways to help smokers quit during routine lung cancer screening.
- What could go wrong
- This is an early-phase study comparing counseling methods, not testing new drugs. Results may not apply to all smokers, and quitting rates may be modest.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Early phase 1
The earliest testing in people: a first look at safety, in a very small group.
- Participants
-
630 people
The number who actually took part.
- Started
-
Jun 2017
- Expected to finish
-
Jun 2026
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
50 years and older
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Age: 50 or older * Meets guidelines for lung cancer screening, as determined by radiology team * Reports being a daily or non-daily smoker (any self-reported smoking in the past 30days) and is interested in treatment that might change smoking behavior. * Able to follow verbal and written instructions in English and complete all aspects ofthe study. * Provide informed consent and agree to all assessments and study procedures. * Have an address where he/she can receive mail * If opting to participate in telemedicine visits, must have a device available to conduct telehealth visits (e.g., smartphone, computer, tablet, etc.). * Be the only participant in his/her household on active treatment in Protocol 2016-0626at the time. * Willing and able to undergo low dose CT scan, as determined by radiology team, and has either had a lung cancer screen within 30 days prior to enrollment into this protocol or schedules a LDCT scan for lung cancer screening to occur while taking part in the 2016-0626 protocol. Exclusion Criteria: * Current enrollment or plans to enroll in another smoking cessation program in the next6 months. * Unwilling to refrain from other nicotine substitutes use (i.e., OTC orprescription medication for smoking cessation) or smoking cessation treatments during the course of the the active treatment portion of the study other than what is provided to or recommended for use. * Current use of certain medications: (1) Smoking cessation meds (last 7 days), that are being used as part of a current attempt to quit smoking i.e., Wellbutrin, Bupropion, Zyban, NRT, Chantix. * Being pregnant, engaging in breast-feeding, or being of childbearing potential and engaging in sexual activity that could lead to pregnancy and is not protected by a medically acceptable, effective method of birth control while enrolled in the study, as determined by self-report..Medically acceptable contraceptives include: (1) approved hormonal contraceptives (such asbirth control pills, patches, implants or injections), (2) barrier methods (such as a condomor diaphragm) used with a spermicide, or (3) an intrauterine device (IUD).Contraceptive measures sold for emergency use after unprotected sex are not acceptable methodsfor routine use. * Exclusive use of tobacco products other than cigarettes or little cigars, such as (but not limited to) cigars, chew, snuff, pipe or e-cigs. * Individuals who are considered clinically unstable and/or unsuitable to participate as determined by the Principal Investigator and/or study physician
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Smoking cessation are added.
Genom att skicka in godkänner du våra Användarvillkor
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Texas MD Anderson Cancer Center
Houston, Texas, 77030, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Texts and wearables team up to help latinos quit smoking and get moving
- Can an AI chatbot help cancer patients kick the habit?
- Does the clock matter? scientists randomize when Quit-Smoking chatbots ping you
- Can a WhatsApp message help smokers quit?
- Practice quitting: a new way to help smokers who Aren't ready to stop?
- Can a Quit-Smoking program built for transgender adults help them stop?